Addenda Capital Inc.’s Canadian Nat Res Ltd Med Ter Position
Does Addenda Capital Inc. own Canadian Nat Res Ltd Med Ter (CRC)? Yes — 1.82M shares worth $104M (+2.81% of its 13F portfolio) as of Q2 2026, up from 1.81M shares the prior filed quarter.
Position Value
$104M
Q2 2026
Shares
1.82M
% of Portfolio
+2.81%
Quarters Held
31
currently held
Position History CRC
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 1.82M | $104M | +2.81% |
| Q1 2026 | 1.81M | $124M | +3.49% |
| Q4 2025 | 1.91M | $90M | +2.64% |
| Q3 2025 | 2.18M | $98M | +2.90% |
| Q2 2025 | 2.37M | $103M | +3.69% |
| Q1 2025 | 2.14M | $96M | +3.55% |
| Q4 2024 | 2.33M | $105M | +3.69% |
| Q3 2024 | 2.41M | $110M | +3.91% |
| Q2 2024 | 2.31M | $114M | +4.46% |
| Q1 2024 | 1.20M | $125M | +4.74% |
| Q4 2023 | 1.35M | $118M | +4.62% |
| Q3 2023 | 1.34M | $119M | +5.19% |
| Q2 2023 | 1.28M | $97M | +4.06% |
| Q1 2023 | 1.32M | $100M | +4.12% |
| Q4 2022 | 1.27M | $97M | +4.21% |
| Q3 2022 | 1.30M | $85M | +3.88% |
| Q2 2022 | 1.30M | $91M | +4.36% |
| Q1 2022 | 1.28M | $100M | +4.11% |
| Q4 2021 | 1.09M | $59M | +2.53% |
| Q3 2021 | 1.09M | $51M | +2.40% |
| Q2 2021 | 1.12M | $51M | +2.38% |
| Q1 2021 | 769.7K | $24M | +1.22% |
| Q4 2020 | 769.7K | $19M | +1.18% |
| Q3 2020 | 883.8K | $14M | +1.04% |
| Q2 2020 | 336.7K | $6M | +0.41% |
| Q1 2020 | 17.4K | $393,000 | +0.03% |
| Q4 2019 | 1.68M | $55M | +3.64% |
| Q3 2019 | 1.50M | $40M | +2.85% |
| Q2 2019 | 1.54M | $42M | +3.05% |
| Q1 2019 | 1.60M | $44M | +3.21% |
| Q4 2018 | 1.64M | $40M | +3.50% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Addenda Capital Inc.’s full portfolio or all institutional holders of CRC.